Back
Astellas Pharma 10K Form
Buy
51
ALPMY
Astellas Pharma
Last Price:
11.68
Seasonality Move:
0.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ALPMY News And Ratings
See the #1 stock for the next 7 days that we like better than ALPMY
ALPMY Financial Statistics
Sales & Book Value
Annual Sales: | $11.11B |
---|---|
Cash Flow: | $366.7M |
Price / Cash Flow: | 0 |
Annual Sales: | $5.88 |
Price / Book: | 1.98 |
Profitability
EPS (TTM): | 0.05830 |
---|---|
Net Income (TTM): | $105.19M |
Gross Margin: | $9.09B |
Return on Equity: | 0.97% |
Return on Assets: | 0.47% |
Astellas Pharma Earnings Forecast
Key Astellas Pharma Financial Ratios
- The Gross Profit Margin over the past 21 years for ALPMY is 81.76%.
- The Selling, General & Administrative Expenses for ALPMY have been equal to 46.15% of Gross Profit Margin.
- The Research & Development expenses have been 18.34% of Revenue.
- The Interest Expense is 70.43% of Operating Income.
- The Net Earning history of ALPMY is 1.06% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 10 years.
Astellas Pharma Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | ALPMY |
Website: | astellas.com |
Debt
Debt-to-Equity Ratio: | 0.58 |
---|---|
Current Ratio: | 0.93 |
Quick Ratio: | 0.71 |
Price-to-Earnings
Trailing P/E Ratio: | 177.98 |
---|---|
Forward P/E Ratio: | 0 |
ALPMY Technical Analysis vs Fundamental Analysis
Buy
51
Astellas Pharma (ALPMY)
is a Buy
Is Astellas Pharma a Buy or a Sell?
-
Astellas Pharma stock is rated a Buy
The current Astellas Pharma [ALPMY] share price is $11.68. The Score for ALPMY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.